300 related articles for article (PubMed ID: 19898566)
21. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
[No Abstract] [Full Text] [Related]
22. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
Moonis M
Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
[No Abstract] [Full Text] [Related]
23. Advances in stroke management: update 1998.
Hacke W
Neurology; 1999; 53(7 Suppl 4):S1-2. PubMed ID: 10532642
[No Abstract] [Full Text] [Related]
24. Thrombolysis in the 3- to 4.5-hour window: what do ECASSkeptics want?
Selim MH; Molina CA
Stroke; 2014 Mar; 45(3):916-7. PubMed ID: 24526059
[No Abstract] [Full Text] [Related]
25. Randomised trials of endovascular treatment of stroke are needed.
Ciccone A; Sterzi R
Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033
[No Abstract] [Full Text] [Related]
26. Intravenous thrombolysis for acute ischaemic stroke: effective blood pressure control matters.
Tsivgoulis G; Kotsis V; Giannopoulos S
Int J Stroke; 2011 Apr; 6(2):125-7. PubMed ID: 21371274
[TBL] [Abstract][Full Text] [Related]
27. Tissue rather than time-based thrombolysis in stroke.
Yaghi S
Int J Stroke; 2013 Aug; 8(6):E33. PubMed ID: 23879757
[No Abstract] [Full Text] [Related]
28. Thrombolytic therapy for acute stroke--not a moment to lose.
Lyden P
N Engl J Med; 2008 Sep; 359(13):1393-5. PubMed ID: 18815401
[No Abstract] [Full Text] [Related]
29. [Treatment of acute ischemic apoplexy].
Andersen G; Krieger DW; Iversen HK
Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
[No Abstract] [Full Text] [Related]
30. Advantages of a combined approach to recanalization therapy.
Nichols C; Khatri P; Tomsick T; Broderick J
Stroke; 2008 Apr; 39(4):e71; author reply e72. PubMed ID: 18309159
[No Abstract] [Full Text] [Related]
31. Real-time monitoring of recanalization after intravenous thrombolysis for acute ischemic stroke.
Delgado-Mederos R; Ribó M; Montaner J; Arenillas JF; Rubiera M; Alvarez-Sabín J; Molina CA
Eur J Neurol; 2006 Apr; 13(4):426-7. PubMed ID: 16643326
[No Abstract] [Full Text] [Related]
32. Intravenous tissue plasminogen activator in central retinal artery occlusion.
Falavarjani KG; Modarres M
Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
[No Abstract] [Full Text] [Related]
33. Is acute stroke treatment heading towards a more endovascular approach?
Menon BK; Demchuk AM
Lancet Neurol; 2009 Sep; 8(9):778-9. PubMed ID: 19647487
[No Abstract] [Full Text] [Related]
34. Stroke: advances in thrombolysis.
Kaste M
Lancet Neurol; 2013 Jan; 12(1):2-4. PubMed ID: 23237887
[No Abstract] [Full Text] [Related]
35. [Waran following thrombolysis with Actilyse].
Ohlsson S; Böttiger Y
Lakartidningen; 2006 Mar 15-21; 103(11):853. PubMed ID: 16613115
[No Abstract] [Full Text] [Related]
36. What Matters in the Results of Repeated Intravenous Thrombolysis for Recurrent Ischemic Stroke?
Wu J; Huang Q; Ma QF
Eur Neurol; 2016; 75(3-4):150-4. PubMed ID: 26950942
[No Abstract] [Full Text] [Related]
37. Room for improvement in stroke treatment.
Health News; 2000 May; 6(5):5. PubMed ID: 10851967
[No Abstract] [Full Text] [Related]
38. Thrombolytics for hyperacute stroke in children.
Amlie-Lefond C; Fullerton HJ
Pediatr Hematol Oncol; 2009; 26(3):103-7. PubMed ID: 19382031
[TBL] [Abstract][Full Text] [Related]
39. Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues.
Matz K; Brainin M
Expert Rev Neurother; 2013 Feb; 13(2):177-85. PubMed ID: 23368805
[TBL] [Abstract][Full Text] [Related]
40. Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke.
Gill D; Halsey L; Kalkat H; Patel S; Kar A
Int J Stroke; 2016 Feb; 11(2):NP25-6. PubMed ID: 26783320
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
